🇵🇱Vivid Mind
Seсtor
Country
Money raised
Founded
Sector: MedTech / AI Diagnostics / Digital Health Type: Seed-stage startup Headquarters: Warsaw, Poland Founded:2022 Founders: Juliusz Donajski (CEO), Jędrzej Kardach (CTO), Dariusz Wiatr (BizDev), Elżbieta Trypka, PhD (Medical Lead), Piotr Zioło, PhD (AI Research) Website: vividmind.health
Overview
Vivid Mind is a Polish deep tech startup developing AI-powered voice diagnostics for early detection of cognitive disorders such as dementia and Alzheimer’s disease. Its flagship product, Memeo Health, enables clinicians to screen for cognitive decline using just 6 seconds of voice input — without collecting personal data. The solution is designed for use in primary care, telemedicine, and clinical research, offering a fast, non-invasive, and scalable alternative to traditional neuropsychological testing.
Product Highlights
- Memeo Health Platform: Mobile and web-based tool for cognitive screening via voice biomarkers
- AI Voice Engine: Analyzes acoustic features such as jitter, hesitation, harmonic frequency, and articulation patterns
- Privacy-First Design: No personal data or speech content is stored or processed
- Clinical Readiness: Preparing for multi-site clinical trials in Q4 2025 in partnership with Polish and German hospitals
- Use Cases: Primary care, geriatric clinics, pharma trials, and digital therapeutics
Funding & Growth
- Total Funding Raised: $200K
- Latest Round: Seed round in December 2024, led by ReaktorX and angel investors including Prof. Bernd Schmitt (Columbia University)
- Accelerator Support: Backed by xdeck (Germany) and EIT Health
- Patents: 1 granted patent on voice-based cognitive screening (2024)
- Employees: 6 (as of 2025)
Business Model & Market
Vivid Mind operates a B2B SaaS model, licensing its platform to healthcare providers, research institutions, and pharmaceutical companies. Its core value lies in enabling early, accessible, and scalable cognitive diagnostics — a critical need in aging societies. The company is part of a growing wave of AI-first healthtech startups redefining preventive care and digital biomarkers.